Robert S. Livingston

2.3k total citations
74 papers, 1.5k citations indexed

About

Robert S. Livingston is a scholar working on Infectious Diseases, Aerospace Engineering and Surgery. According to data from OpenAlex, Robert S. Livingston has authored 74 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 15 papers in Aerospace Engineering and 12 papers in Surgery. Recurrent topics in Robert S. Livingston's work include Viral gastroenteritis research and epidemiology (17 papers), Particle accelerators and beam dynamics (13 papers) and Virus-based gene therapy research (11 papers). Robert S. Livingston is often cited by papers focused on Viral gastroenteritis research and epidemiology (17 papers), Particle accelerators and beam dynamics (13 papers) and Virus-based gene therapy research (11 papers). Robert S. Livingston collaborates with scholars based in United States. Robert S. Livingston's co-authors include Lela K. Riley, Charlie C. Hsu, R. P. Scheffer, Craig L. Franklin, Cynthia Besch‐Williford, Matthew H. Myles, E K Steffen, Christiane E. Wobus, R R Hook and David G. Besselsen and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Robert S. Livingston

73 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert S. Livingston United States 22 539 255 247 230 225 74 1.5k
J. E. van Dijk Netherlands 24 409 0.8× 155 0.6× 255 1.0× 522 2.3× 249 1.1× 86 2.0k
W. David Wilson United States 36 502 0.9× 311 1.2× 170 0.7× 864 3.8× 300 1.3× 137 3.8k
P.R. Wood Australia 31 1.1k 2.0× 272 1.1× 146 0.6× 493 2.1× 178 0.8× 90 2.8k
Douglas Jones United Kingdom 28 129 0.2× 205 0.8× 77 0.3× 204 0.9× 274 1.2× 111 3.1k
L. Bonizzi Italy 26 330 0.6× 85 0.3× 236 1.0× 569 2.5× 179 0.8× 82 1.9k
Takeshi Haga Japan 20 305 0.6× 81 0.3× 135 0.5× 576 2.5× 112 0.5× 102 1.6k
Reisaku Kono Japan 24 791 1.5× 53 0.2× 244 1.0× 198 0.9× 207 0.9× 68 1.6k
Petra Reinhold Germany 25 272 0.5× 158 0.6× 132 0.5× 255 1.1× 225 1.0× 106 1.8k
Ronald A. Greenfield United States 24 781 1.4× 157 0.6× 100 0.4× 243 1.1× 23 0.1× 58 1.8k
Timothy F. Booth Canada 25 1.0k 1.9× 65 0.3× 191 0.8× 675 2.9× 167 0.7× 49 2.3k

Countries citing papers authored by Robert S. Livingston

Since Specialization
Citations

This map shows the geographic impact of Robert S. Livingston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Livingston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Livingston more than expected).

Fields of papers citing papers by Robert S. Livingston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Livingston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Livingston. The network helps show where Robert S. Livingston may publish in the future.

Co-authorship network of co-authors of Robert S. Livingston

This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Livingston. A scholar is included among the top collaborators of Robert S. Livingston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Livingston. Robert S. Livingston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arbona, Rodolfo J Ricart, et al.. (2023). Effects of Mouse Kidney Parvovirus on Pharmacokinetics of Chemotherapeutics and the Adenine Model of Chronic Kidney Disease. Comparative Medicine. 73(2). 153–172. 1 indexed citations
2.
Zaias, Julia, et al.. (2019). Seroconversion of 1-year-old Mice to Murine Norovirus. Journal of the American Association for Laboratory Animal Science. 58(2). 197–200. 1 indexed citations
3.
Upendran, Anandhi, Cynthia Besch‐Williford, Robert S. Livingston, et al.. (2015). Delayed and Aberrant Presentation of VX2 Carcinoma in a Rabbit Model of Hepatic Neoplasia.. PubMed. 65(5). 424–8. 1 indexed citations
4.
Kahan, Shannon M., Guangliang Liu, Mary K. Reinhard, et al.. (2011). Comparative murine norovirus studies reveal a lack of correlation between intestinal virus titers and enteric pathology. Virology. 421(2). 202–210. 52 indexed citations
5.
Reuter, Jon D., Robert S. Livingston, & Mathias Leblanc. (2011). Management strategies for controlling endemic and seasonal mouse parvovirus infection in a barrier facility. Lab Animal. 40(5). 145–152. 13 indexed citations
6.
Livingston, Robert S., Cynthia Besch‐Williford, Matthew H. Myles, et al.. (2011). Pneumocystis carinii infection causes lung lesions historically attributed to rat respiratory virus.. PubMed. 61(1). 45–59. 17 indexed citations
7.
Myles, Matthew H., et al.. (2011). In vivo tropisms and kinetics of rat theilovirus infection in immunocompetent and immunodeficient rats. Virus Research. 160(1-2). 374–380. 1 indexed citations
8.
Riley, Lela K., et al.. (2010). Evaluation of a commercial colorimetric fecal dipstick assay for the detection of Helicobacter hepaticus infections in laboratory mice.. PubMed. 49(3). 312–5. 3 indexed citations
9.
Myles, Matthew H., et al.. (2010). Perturbations in cytokine gene expression after inoculation of C57BL/6 mice with Pasteurella pneumotropica.. PubMed. 60(1). 18–24. 22 indexed citations
10.
Cohn, Leah A., et al.. (2007). Response of healthy dogs to infusions of human serum albumin. American Journal of Veterinary Research. 68(6). 657–663. 57 indexed citations
11.
Hsu, Charlie C., Lela K. Riley, & Robert S. Livingston. (2006). Molecular characterization of three novel murine noroviruses. Virus Genes. 34(2). 147–155. 42 indexed citations
12.
Livingston, Robert S., David G. Besselsen, E K Steffen, et al.. (2002). Serodiagnosis of Mice Minute Virus and Mouse Parvovirus Infections in Mice by Enzyme-Linked Immunosorbent Assay with Baculovirus-Expressed Recombinant VP2 Proteins. Clinical and Vaccine Immunology. 9(5). 1025–1031. 31 indexed citations
13.
Sindhi, Rakesh, Mariano F. LaVia, Emily E. Paulling, et al.. (2000). STIMULATED RESPONSE OF PERIPHERAL LYMPHOCYTES MAY DISTINGUISH CYCLOSPORINE EFFECT IN RENAL TRANSPLANT RECIPIENTS RECEIVING A CYCLOSPORINE+RAPAMYCIN REGIMEN1. Transplantation. 69(3). 432–436. 83 indexed citations
14.
Basarab, Gregory S., et al.. (1992). Design of Sterol Reductase Inhibitors. Insights into the Binding Conformation of Tertiary Amine Fungicides.. 414–427. 1 indexed citations
15.
Weinberg, Alvin M., et al.. (1985). The Second Nuclear Era: A New Start for Nuclear Power. Medical Entomology and Zoology. 16 indexed citations
16.
Livingston, Robert S., et al.. (1985). The Longevity of Nuclear Power Systems. Nuclear Science and Engineering. 90(4). 501–508. 1 indexed citations
17.
Livingston, Robert S., et al.. (1964). AN ISOCHRONOUS CYCLOTRON MESON FACTORY. 1 indexed citations
18.
Boom, R., Louis D. Roberts, & Robert S. Livingston. (1963). Developments in superconductor solenoids. Nuclear Instruments and Methods. 20. 495–502. 12 indexed citations
19.
Livingston, Robert S., et al.. (1955). RADIOISOTOPE PRODUCTION RATES IN A 22-MEV CYCLOTRON. Nucleonics (U.S.) Ceased publication. 6 indexed citations
20.
Livingston, Robert S., et al.. (1955). ORNL'S DESIGN FOR A POWER REACTOR PACKAGE. Nucleonics (U.S.) Ceased publication. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026